Scrambler therapy

Scrambler therapy (sometimes Calmare scrambler therapy or Calmare therapy) involves the use of electronic stimulation on the skin with the goal of overwhelming pain information with non-pain information.[1] In a therapy session, "electrocardiographic-like pads are placed around the area of pain".[2]

The technique was invented by Giuseppe Marineo at the University of Rome Tor Vergata.[3] Marineo co-authored and published a research paper, "Scrambler therapy": a new option in neuropathic pain treatment?," in 2000.[4]

There is not much research on the efficacy of scrambler therapy.[5] There is no strong evidence that it is effective in treating neuropathic pain.[6] Although there is tentative evidence that it may be effective for chemotherapy-induced peripheral neuropathy.[5]

See also

References

  1. ↑ Katholi BR, Daghstani SS, Banez GA, Brady KK (2014). "Noninvasive treatments for pediatric complex regional pain syndrome: a focused review". PM&R 6 (10): 926–33. doi:10.1016/j.pmrj.2014.04.007. PMID 24780851.
  2. ↑ Harrison, Pam (11 Jan 2016). "Scrambler Therapy Benefit in Cancer-Related Neuropathic Pain". Medscape (WebMD LLC). Retrieved 24 January 2016.
  3. ↑ Anson, Pat (9 April 2014). "Inventor of Calmare Scrambler Tries to Block Sales". National Pain Report.
  4. ↑ Serafini, G., Marineo, G. and Sabato, A.F. (2000). "Scrambler therapy": a new option in neuropathic pain treatment?". The Pain Clinic 12 (4): 287–298. doi:10.1163/156856900750233785.
  5. 1 2 Pachman, DR; Watson, JC; Loprinzi, CL (December 2014). "Therapeutic strategies for cancer treatment related peripheral neuropathies.". Current treatment options in oncology 15 (4): 567–80. doi:10.1007/s11864-014-0303-7. PMID 25119581.
  6. ↑ Rivera, E., & Cianfrocca, M. (2015). "Overview of neuropathy associated with taxanes for the treatment of metastatic breast cancer". Cancer Chemotherapy and Pharmacology 75 (4): 659–670. doi:10.1007/s00280-014-2607-5. PMC 4365177. PMID 25596818.
This article is issued from Wikipedia - version of the Wednesday, March 30, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.